Back

Absolute coronary flow and microvascular resistance before and after TAVR

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Physiology matters: pushing the boundaries of invasive functional assessment applications Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Emanuele Gallinoro

Sant Andrea Hospital, Rome (Italy)

7 More presentations in this session

Presentation thumbnail
Cycling coupled to intra-coronary thermodilution to evaluate angina with non-obstructive coronary artery disease
Doctor G. Rahoual (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Safety and feasibility of nationwide invasive coronary function testing in patients with angina and no obstructive coronary artery disease (NL-CFT).
Ms C. Crooijmans (Nijmegen, NL)
Abstract Slides Video
Presentation thumbnail
Intracoronary nicardipine to induce hypaeremia
Doctor T. Mahendiran (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Comparison of adenosine, dobutamine and bicycle exercise on intracoronary physiological indices in patients with myocardial bridges
Doctor A. Sinha (London, GB)
Abstract Slides Video
Presentation thumbnail
Coronary microvascular dysfunction in heart failure: observations from the MICRO registry
Doctor O. Velollari (Mainz, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Physiology matters: pushing the boundaries of invasive functional assessment applications

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
How to interpret coronary physiology in patients with severe aortic stenosis and coronary artery disease before and after valve replacement ?
thumbnail
Congress Presentation
The effect of transcatheter aortic valve implantation on fractional flow reserve and non-hyperemic pressure ratios
thumbnail
Congress Presentation
Microvascular functional assessment using microvascular resistance reserve in patients undergoing elective fractional flow reserve-guided percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources